Skip to main content

Table 4 Comparision of the status of lipidemia between breast cancer patients with pre and post chemotherapy

From: Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy

Parameter Pre-chemotherapy group(n = 394) Post-chemotherapy group (n = 394)
Mean ± SD (mmol/L) Abnormal (n, %) Mean ± SD (mmol/L) Abnormal (n, %)
TC 4.47 ± 0.91** 79(20.05)** 4.80 ± 0.88 119(30.20)
TG 1.31 ± 1.20** 72(18.27)** 1.77 ± 1.21 160(40.61)
HDL-C 1.43 ± 0.36** 20(5.08)* 1.28 ± 0.35 42(10.66)
LDL-C 2.78 ± 0.80** 135(34.26)** 3.15 ± 0.81 203(51.52)
Apo-A1 1.48 ± 0.25** 10(2.54)** 1.39 ± 0.24 35(8.88)
Apo-B 0.85 ± 0.23** 11(2.79) 0.97 ± 0.24 20(5.08)
Dyslipidemia 201(45.07) ** 306(68.61)
  1. *p < 0.05 **p < 0.001 comparision of the status of lipidemia between pre and post chemotherapy among breast cancer patients; TC: total-cholesterol, TG: triglyceride, HDL-C: high density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, Apo-A1: apolipoprotein-A1, Apo-B: apolipoprotein-B